Project Grant HT9425261E298
Award Date 8/1/26
Completion Date 7/31/28
Dollars Obligated $560K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19107, USA
Similar Awards
- Federal Grant Award Summary Thomas Jefferson University, operating as Sidney Kimmel Medical College, received a $624,000 Project Grant award dated July 15, 2025, from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The award supports research to identify mechanisms of tolerance and resistance to darovasertib plus crizotinib in uveal melanoma, with a performance period extending through July 14, 2027. This research addresses critical...
- Federal Grant Award Summary Thomas Jefferson University, operating as Sidney Kimmel Medical College, received a $1,998,484 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2029. The award funds biomedical research titled "Deciphering the Role of PIK3CA Mutations in Tumorigenesis of HER2-Positive Breast Cancer," with research activities conducted at the...
- Federal Project Grant Award Summary Thomas Jefferson University (operating as Sidney Kimmel Medical College) received a $1.35 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2030. This four-year award supports identification and evaluation of immune and targeted therapies for acral melanoma, a rare form of melanoma affecting the military and general populations. The...
- Federal Grant Award Summary Thomas Jefferson University, operating as Sidney Kimmel Medical College, received a $3.12 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2029. The award supports research and development activities focused on novel tumor-targeted immunotherapies against metastatic uveal melanoma. This research initiative will be conducted at the...
- Federal Grant Award Summary Thomas Jefferson University, operating as Sidney Kimmel Medical College, received a $819,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, with a completion date of April 30, 2028. The award funds research investigating chromium (VI)-driven profibrotic microenvironment and its contribution to lung carcinogenesis, addressing a critical occupational and environmental...
- Federal Project Grant Award Summary Thomas Jefferson University, operating as Sidney Kimmel Medical College, received a $1.1 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2030. The project, titled "Chemoradiation Imparts KRAS-Mediated Resistance to Immunotherapy in Non-Small Cell Lung Cancer," supports basic and applied biomedical research addressing Service...
- The Defense Health Agency awarded a $756,897 Project Grant to Thomas Jefferson University, doing business as the Sidney Kimmel Medical College, for the federal grant program "Military Medical Research and Development" (CFDA 12.420). The grant, effective August 1, 2024 through July 31, 2027, will support "Second-Generation Precision Medicine for BRCA-Mutant Ovarian Cancer" research. Thomas Jefferson University, a leading academic medical center known for its innovative medical...
- This federal Project Grant award of $858,000.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports a longitudinal analysis of the mesenchymal cell state from melanoma initiation to metastatic progression at Thomas Jefferson University's Sidney Kimmel Medical College. The award, effective August 1, 2024, with a completion date of July 31, 2027, funds advanced biomedical research aimed at transforming healthcare for...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a $560,000 Project Grant effective September 15, 2026, through September 14, 2028, under the Military Medical Research and Development program (CFDA 12.420). The project, titled "Targeting the Nascent Polypeptide-Associated Complex (NAC) to Block Oncogenic Myristoylation in Diffuse Large B-Cell Lymphoma," involves investigator-initiated biomedical research focused on understanding...
- Federal Grant Award Summary The Johns Hopkins University received a $606,060 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 15, 2025 through July 14, 2027. The project, titled "Engineering Receptors to Promote Effective Infiltration of CAR T Cells into Bladder Tumors," supports advanced biomedical research aimed at developing innovative cancer immunotherapy approaches relevant to...